miR-100a and miR-10 were significantly increased in the pancreatic cancer patients compared to non-cancer controls while a number of the other miRs (miR-16, 21, 155, 199, 221, and 223) showed a trend of increased expression that did not reach statistical significance ( Figure 5A ).
← all excerpts
Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer.
1
—
—